Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Explore Which Dividend Aristocrats Etf Is Best For Retirement, focusing on income reliability, cost, and suitability for a retirement portfolio.
23,402 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
The Federal Reserve left its policy rate unchanged at its March 2026 meeting as inflation cools but the jobs market r...
Benchmark lowered its Bakkt price target by about 47%, arguing that near-term monetization remains elusive as the com...
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
Brent crude climbs to $113.71 per barrel on March 19, 2026, as traders weigh supply discipline and demand signals. He...
Tesla shares slipped as three major developments tug the stock in mixed directions: stricter autonomous driving overs...
Webull rolled out a March 2026 cash-bonuses program, offering tiered deposit matches and a first-transfer reimburseme...
The FBI has issued a warning about spoof tokens targeting Tron wallets, deploying as TRC-20 assets to threaten asset ...
A sharp one-week drop surprised many investors. This analysis explains the drivers behind the decline, from KPI discl...
U.S. prosecutors in New York investigate links between Colombia's president and drug traffickers, while the DEA desig...
Amazon is pursuing a colossal 2026 investment plan centered on AI and cloud tech. This guide breaks down the risks, p...